Hair loss pattern due to chemotherapy-induced anagen effluvium: A cross-sectional observation

Dermatology

Volumn 215, Issue 1, 2007, Pages 36-40

  Yun, Sook Jung ^a   Kim, Seong Jin ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Anagen effluvium; Chemotherapeutic agents; Patterned hair loss

Indexed keywords

ALKYLATING AGENT; ANTIMETABOLITE; BLEOMYCIN; BUSULFAN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; HYDROXYUREA; IDARUBICIN; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; MITOMYCIN C; TOPOTECAN; VINCA ALKALOID;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; FEMALE; HAIR GROWTH; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; ALOPECIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HAIR; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SCALP DERMATOSES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 34250884497     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102031     Document Type: Article

References (18)

1. Batchelor D: Hair and cancer chemotherapy: consequences and nursing care - A literature study. Eur J Cancer Care 2001;10:147-163.
2. Williamson PJ, de Berker D: Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease. Br J Haematol 2005;128:582.
3. Koppel RA, Boh EE: Cutaneous reactions to chemotherapeutic agents. Am J Med Sci 2001;321:327-335.
4. Espinosa EE, Zamora P, Feliu J, Baron MG: Classification of anticancer drugs - A new system based on therapeutic targets. Cancer Treat Rev 2003;29:515-523.
5. Hussein AM: Chemotherapy-induced alopecia: new developments. Southern Med J 1993;86:489-496.
6. Kiebert GM, Hanneke J, De Haes CJM, Kievit J, Van de Velde CJH: Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer. Eur J Cancer 1990;26A:1038-1042.
7. Paus R, Cotsarelis G: The biology of hair follicles. N Engl J Med 1999;341:491-497.
8. Dunagin WG: Dermatological toxicity; in Perry MC, Yarbro JW (eds): Toxicity of chemotherapy. New York, Grune & Stratton, 1984, pp 125-145.
9. Botchkarev VA: Molecular mechanisms of chemotherapy-induced hair loss. JID Symp Proc 2003;8:72-75.
10. Sharov AA, Li GZ, Palkina TN, Sharova TY, Gilchrest BA, Botchkarev VA: Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss. J Invest Dermatol 2003;120:27-35.
11. Howser DM: Alopecia - The problem of alopecia in cancer; in Groenwald SL, Frogge MH, Goodman M, et al (eds): Cancer Symptom Management. Boston, Jones & Bartlett, 1996, pp 261-268.
12. Olsen EA: Female pattern hair loss. J Am Acad Dermatol 2001;45(suppl):S70-80.
13. Norwood OT: Male pattern baldness: classification and incidence. South Med J 1975;68: 1359-1365.
14. Hamilton JB: Patterned loss of hair in men: types and incidence. Ann NY Acad Sci 1951;53:708-723.
15. Ludwig E: Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977;97:247-254.
16. Sinclair R: Diffuse hair loss. Int J Dermatol 1999;38:8-18.
17. Sawaya ME, Price VH: Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997;144:297-304.
18. Madani S, Shapiro J: Alopecia areata update. J Am Acad Dermatol 2000;42:549-566.